# Can patiromer allow for intensified renin–angiotensin–aldosterone system blockade with losartan and spironolactone leading to decreased albuminuria in patients with chronic kidney disease, albuminuria and hyperkalaemia? An open-label randomised controlled trial: MorphCKD

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/can-patiromer-allow-for-intensified-renin-angiotensin-aldosterone-system/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Frederik Husum Mårup,Christian D. Peters,Jeppe Hagstrup Christensen,Henrik Birn |
| Citations | 13 |
| DOI | 10.1136/bmjopen-2021-057503 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://bmjopen.bmj.com/content/bmjopen/12/2/e057503.full.pdf |
| OpenAlex ID | https://openalex.org/W4213069846 |
| PMID | 35190442 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Frederik Husum Mårup](https://scholariq.org/researchers/frederik-husum-marup/)

## Paper journal

- [BMJ Open](https://scholariq.org/journals/bmj-open/)

## Paper primary topic

- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)

## Paper topics

- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.